For research purposes only. Not for human consumption. Not medical advice.
Cagrilintide
Price updated daily
Weight Loss & Metabolic Health
Cagrilintide is a long-acting amylin analogue in clinical development, often studied in combination with semaglutide (CagriSema). Amylin complements GLP-1 by promoting satiety through distinct central nervous system pathways. The combination approach targets multiple hormonal axes for additive weight loss.
Research Use Cases
- Complementary satiety signaling with GLP-1 agents
- Enhanced weight loss combination therapy
- Metabolic research
Note: Investigational. Currently in Phase 3 trials (CagriSema).